Liver fibrosis in overweight patients

Gastroenterology

Volumn 118, Issue 6, 2000, Pages 1117-1123

  Ratziu, Vlad ^a,b   Giral, Philippe ^a   Charlotte, Frederic ^a   Bruckert, Eric ^a   Thibault, Vincent ^a   Theodorou, Ioannis ^a   Khalil, Lina ^a   Turpin, Gérard ^a   Opolon, Pierre ^a   Poynard, Thierry ^a,b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; TRIACYLGLYCEROL;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BODY MASS; FEMALE; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034116558     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(00)70364-7     Document Type: Article

References (31)

1. MR Teli OFW James D Burt MK Bennett CP Day The natural history of nonalcoholic fatty liver: a follow-up study Hepatology 22 1995 1714 1719
2. CA Matteoni ZM Younossi T Gramlich N Boparai YC Liu AJ McCullough Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity Gastroenterology 116 1999 1413 1419
3. SH Caldwell DH Oelsner JC Iezzoni EE Hespenheide EH Battle CJ Driscoll Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease Hepatology 29 1999 664 669
4. RJ Kuczmarski KM Flegal SM Campbell CL Johnson Increasing prevalence of overweight among US adults JAMA 272 1994 205 211
5. Metropolitan Life Insurance Co 1970 Build study 1980 Society of Actuaries and Associations of Life Insurance Medical Directors of America Chicago, IL
6. JG Kral S Heymsfield Morbid obesity: definitions, epidemiology, and methodological problems Gastroenterol Clin North Am 16 1987 197 205
7. FJ Garcia F Garcia MC Bernal A Leyva G Piedrola MC Maroto Evaluation of enzyme immunoassay for hepatitis B virus DNA based on anti-double-stranded DNA J Clin Microbiol 33 1995 413 415
8. IM Roitt D Doniach Immunofluorescent test for the detection of antibodies World Health Organization WHO Booklet of Immunological Studies 1972 1 12 Geneva, Switzerland
9. EC Jazwinska LM Cullen F Busfield WR Pyper SI Webb LW Powell CP Morris TP Walsh Haemochromatosis and HLA-H Nat Genet 14 1996 249 251
10. F Imbert-Bismut F Charlotte B Turlin L Khalil A Piton P Brissot YL Charpentier J Delattre P Opolon Y Deugnier T Poynard Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoring J Clin Pathol 52 1999 430 434
11. The French METAVIR Cooperative Study Group Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C Hepatology 20 1994 15 20
12. ZM Younossi T Gramlich YC Liu C Matteoni M Petrelli J Goldblum L Rybicki AJ McCullough Non-alcoholic fatty liver disease: assessment of variability in pathologic interpretations Mod Pathol 11 1998 560 565
13. YM Deugnier O Loreal B Turlin D Guyader H Jouanolle R Moirand C Jacquelinet P Brissot Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations Gastroenterology 102 1992 2050 2059
14. KG Alberti P Zimmet for the WHO Consultation Group Definition, diagnosis, and classification of diabetes mellitus and its complications. Part I. Diagnosis and classification of diabetes mellitus Diabetes Med 15 1998 539 553
15. EE Powell WGE Cooksley R Hanson J Searle JW Halliday LW Powell The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1990 74 80
16. DK George S Goldwurm GA Macdonald LL Cowley NI Walker PJ Ward EC Jazwinska LW Powell Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis Gastroenterology 114 1998 311 318
17. WC Willett WH Dietz GA Colditz Primary care: guidelines for healthy weight N Engl J Med 341 1999 427 434
18. M Adler F Schaffner Fatty liver hepatitis and cirrhosis in obese patients Am J Med 67 1979 811 816
19. P Marceau S Biron F-S Hould S Marceau S Simard SN Thung JG Kral Liver pathology and the metabolic syndrome X in severe obesity J Clin Endocrinol Metab 84 1999 1513 1517
20. JT Galambos CE Wills Relationship between 505 paired liver tests and biopsies in 242 obese patients Gastroenterology 74 1978 1191 1195
21. SM Nasrallah CE Wills JT Galambos Hepatic morphology in obesity Dig Dis Sci 26 1981 325 327
22. A Braillon JP Capron MA Herve C Degott C Quenum Liver in obesity Gut 26 1985 133 139
23. IR Wanless JS Lentz Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors Hepatology 12 1990 1106 1110
24. JF Silverman KF O'Brien S Long N Leggett PG Khazanie WJ Pories T Norris JF Caro Liver pathology in morbidly obese patients with and without diabetes Am J Gastroenterol 85 1990 1349 1355
25. J Klain D Fraser J Goldstein J Peiser E Avinoah A Ovnat I Charuzi Liver histology abnormalities in the morbidly obese Hepatology 10 1989 873 876
26. O James C Day Non-alcoholic steatohepatitis: another disease of affluence Lancet 353 1999 1634 1636
27. CP Day OFW James Hepatic steatosis: innocent bystander or guilty party? Hepatology 27 1998 1463 1466
28. SQ Yang HZ Lin MD Lane M Clemens AM Diehl Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis Proc Natl Acad Sci U S A 94 1997 2557 2562
29. KD Chavin S Yang HZ Lin J Chatham VP Chacko JB Hoeck E Walajtys-Rode A Rashid CH Chen CC Huang TC Wu MD Lane AM Diehl Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion J Biol Chem 274 1999 5692 5700
30. S Naveau V Giraud E Borotto A Aubert F Capron JC Chaput Excess weight risk factor for alcoholic liver disease Hepatology 25 1997 108 111
31. LF Hourigan GE MacDonald D Purdie VH Whitehall C Shorthouse A Clouston EE Powell Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis Hepatology 29 1999 1215 1219